Answers are grounded in this paper and cite their sources.
Reveals changes in cell types and granule secretion in chick embryos following hormone treatments.
Thyroxine, thiourea and thyroid-releasing factor (T.R.F.) were administered to chick embryos on incubation day 5 and the ultrastructure of the cephalic lobe of the hypophysis was studied on incubation days 8, 10, 12, 14 and 16. On day 8, three cell types are present: Type I, Type II and Type III. On incubation days 10, 12, 14 and 16, five cell types are present: thyrotrope, corticotrope, prolactin cell, melanotrope and gonadotrope. On incubation day 8, the thyroxine, thiourea and T.R.F. treatments caused a significant increase in the number of cytoplasmic granules in cell Type III but effected no change in cell Types I and II. Cell Type III is, therefore, the thyrotrope at this stage. On incubation days 10, 12, 14 and 16, the thyroxine, thiourea and T.R.F. treatments caused significant increases in the number of cytoplasmic granules in the cell classified as the thyrotrope, thus confirming its identification. Generally, these treatments did not influence the granule numbers in the corticotrope, prolactin cell, melanotrope and gonadotrope on the incubation stages studied. The one exception was a decrease in the number of granules in all cell types on incubation day 12 following T.R.F. administration. On incubation day 16, T.R.F. treatment caused an immediate loss in the number of thyrotrope granules, noted at the lh post-treatment stage. At the 2h post-treatment stage the number of thyrotrope granules was similar to that of the control tissues and the number of granules was increased at the 3h, 4h, 6h and 18h stages. Thus, the T.R.F. stimulated an initial high rate of thyrotrope granule secretion followed by a period of increased synthesis.
No takes yet. Share an insight, caveat, or question.
Marlene Dawn Henry (1978) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: